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INTRODUCTION
Hypertensive disorders of pregnancy (HDP; including 
gestational hypertension and pre-eclampsia) are serious 
complications during pregnancy, and women affected have 
higher risk of post-pregnancy cardiometabolic disease.1 
Furthermore, the children born to these affected women and 
exposed to maternal HDP also have higher blood pressure2 
and body mass index (BMI)3 compared with children born 
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BACKGROUND
Women with a history of hypertensive disorders of pregnancy (HDP) 
are at increased risk of hypertension, cardiovascular disease, and type 
2 diabetes. Offspring from pregnancies complicated by HDP also have 
worse cardiometabolic status in childhood and young adulthood, 
but the offspring risk of clinical hypertension in adulthood is largely 
unknown.
METHODS
We studied 13,893 first-born adult offspring (49.4% female) who  
attended a structured population-based primary care visit (The 
Västerbotten Health Survey) at age 40 years in Sweden between 1994 
and 2013. Data on maternal HDP were collected from a population-based 
birth register. We investigated the association between maternal HDP 
and the risk of adult offspring hypertension and worse cardiometabolic 
risk factor status utilizing multivariable poisson and linear regression 
models. We also conducted a sibling comparison, which inherently 
accounted for familial factors shared by siblings (N = 135).
RESULTS
Offspring participants of women with HDP (N = 383, 2.8%) had increased 
relative risk of hypertension (1.67, 95% confidence interval: 1.38, 2.01) and 
also higher mean body mass index, systolic blood pressure, diastolic blood 
pressure, and worse 2-hour 75 g oral glucose tolerance test result at age 
40 years. No difference was observed for serum cholesterol. Point estimates 
for the cardiometabolic risk factors were attenuated in the sibling analyses.
CONCLUSION
Offspring born to mothers with a history of HDP are on an adverse 
cardiometabolic trajectory and should be considered as concomitant 
targets for primordial prevention of hypertension in the maternal post-
pregnancy period.
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to normotensive mothers. These differences persist in young 
adulthood4 and might even translate into an increased risk of 
type 2 diabetes5 and stroke6 later in life. Results from animal 
models suggest that reduced uterine perfusion and exposure 
to anti-angiogenic factors during gestation—mimicking pre-
eclampsia—can result in higher long-term blood pressure in the 
offspring, potentially mediated through altered cardiovascular 
structure and function.7 Yet, a sibling analysis of young adult 
offspring suggested that the association between maternal 
HDP and offspring cardiometabolic risk factors might be 
largely attributable to shared familial factors.4 However, no 
study has presented clinically measured hypertension data 
on middle-aged adults born to hypertensive or preeclamptic 
women and also included analysis of non-exposed siblings.8
In this study, we investigated the association between 
exposure to maternal HDP and clinically measured offspring 
hypertension and cardiometabolic risk factors at age 
40 years. In a complementary sibling analysis, we attempted 
to determine the extent to which any associations reflected a 
shared propensity for more adverse cardiometabolic health.
METHODS
We utilized data from standardized population-based 
preventive care visits in primary care at age 40  years 
(Västerbotten Health Survey)9,10 and comprehensive 
population-based registries of deliveries.11 Additional data 
on education and place of residence were collected via 
Statistics Sweden. The study was approved by the Regional 
Ethical Review Board at Lund University (2014/337).
Study sample
We used data on first-born individuals who were born 
between 1955 and 1972 in the counties covered by the 
comprehensive birth register (described below) and who 
attended the Västerbotten Health Survey at age 40  years 
between 1994 and 2013. In total, 14,947 first-born participants 
were initially eligible; we further excluded those outside the 
permitted age-range or with missing data on co-variables used 
in the adjusted analyses (Supplementary Figure 1). As there 
were small amounts of missing outcome data, the number of 
participants included in each analysis varied slightly.
Data on maternal HDP
Maternal HDP was ascertained using data from a 
comprehensive regional birth register covering 2 counties 
in northern Sweden. This resource has previously been 
used for epidemiological research.11,12 Maternal HDP (pre-
eclampsia/toxemia/eclampsia/gestational hypertension) 
and any diabetes mellitus during pregnancy were defined 
according to the International Classification of Diseases 
(Supplementary Material). No specific data on pre-
pregnancy hypertension status was available.
Clinical visits at age 40 years
At age 40 years, all residents of the county of Västerbotten 
were invited to a standardized visit in primary care focused 
on cardiometabolic disease prevention. Approximately, 
60% of the eligible population attended.10 The standardized 
study visits were focused on lifestyle, are performed by a 
nurse, and include a self-administered questionnaire on 
previous diagnoses, smoking habits, and family history 
of cardiovascular disease. Body weight and height were 
measured, and we calculated BMI as kg/m2. Systolic 
blood pressure (SBP) and diastolic blood pressure (DBP) 
were measured once with a sphygmomanometer with 
the participant in a supine position before August 2009 
and subsequently twice in a seated position (average 
values used). For analytic purpose, we converted seated 
blood pressure measurements to supine equivalents using 
previously published age- and sex-specific equations based 
on data from the same setting (Supplementary Material).13 
Hypertension was defined either through self-report, current 
anti-hypertensive treatment, or clinical measurement of SBP 
≥140 and/or DBP ≥90 mm Hg.
The visit also included a 75 g 2-hour oral glucose tolerance 
test (OGTT) with capillary sampling. Total serum cholesterol 
was measured using Reflotron bench-top analyzers before 
2009 and was analyzed at the regional clinical chemistry lab 
(at University Hospital of Umeå).
Statistical analysis
First, we investigated the association between maternal 
HDP and offspring relative risk of hypertension at age 
40  years. To do so, we used Poisson regression models 
incrementally adjusted for co-variables. Model I  included 
maternal HDP in index pregnancy, whereas model II (main 
model) additionally included offspring sex, family history 
of cardiovascular disease, and maternal diabetes during 
pregnancy. In model III, we further included education level, 
smoking, and BMI at age 40 years (when BMI was not the 
outcome).
We then investigated the association between maternal 
HDP and offspring BMI, SBP, DBP, 2-hour OGTT result, 
and log-transformed total serum cholesterol, respectively. To 
do this, we utilized linear regression models incrementally 
adjusted for co-variables as above. The use of anti-
hypertensive or lipid-lowering medication was accounted 
for by including constants as previously recommended 
(Supplementary Material).14,15
For the sibling analyses, we established a second cohort 
by identifying siblings who attended the age 40  years visit 
(N = 62 sibships) with at least 1 sibling in each sibship being 
exposed to maternal HDP. We compared cardiometabolic 
risk factors in the sibling cohort by a linear mixed model 
with random family effects to account for multiple offspring 
by the same mother. We adjusted also these analytical models 
incrementally for co-variables. All statistical analyses were 
performed in SAS 9.3 (SAS Institute, Cary, NC).
RESULTS
Of the total study sample (N = 13,893), 383 participants 
(2.8%) were exposed to maternal HDP. At age 40  years, 
there were no substantial differences in smoking status 
or education level between participants exposed and not 
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exposed to maternal HDP. Supplementary Table 1 shows the 
study sample characteristics.
Participants exposed to maternal HDP had a higher 
relative risk of hypertension in model I (1.70, 95% confidence 
interval (CI): 1.41, 2.04), model II (1.67, 95% CI: 1.38, 2.01), 
and in model III (1.52, 95% CI: 1.27, 1.84).
Table 1 shows the associations between maternal HDP and 
continuous cardiometabolic risk factors in exposed offspring 
at age 40 years. Exposure to maternal HDP was associated 
with higher mean BMI, SBP, DBP, and 2-hour OGTT result 
in model II. There was no evidence of an interaction between 
exposure to maternal HDP and offspring sex when analyzing 
the continuous outcomes (P > 0.05, data not shown). Results 
remained similar in analyses accounting for medication with 
dummy variables (data not shown).
Supplementary Table  2 shows the study characteristics 
of the study sample in the sibling analysis by exposure to 
maternal HDP. In total, 135 participants were included. 
There was little evidence of associations of exposure to HDP 
with worse cardiometabolic risk factor profile in siblings, 
with more modest point estimates, i.e., closer to the zero, 
than those found in the population overall. In model II, 
the association for BMI was −0.28  kg/m2 (95% CI: −1.66, 
1.09), for SBP −0.06 mm Hg (95% CI: −4.36, 4.24), for DBP 
0.004  mm Hg (95% CI: −2.96, 2.96), for 2-hour OGTT 
glucose 0.07  mmol/l (95% CI: −0.37, 0.51) and for total 
serum cholesterol 4 % (95% CI: −2%, 9%) (Supplementary 
Table 3).
DISCUSSION
In this study, we for the first time report offspring exposed 
to maternal HDP during pregnancy to have higher risk of 
hypertension based on clinical measurements in middle 
age. Furthermore, we found that exposure to maternal 
HDP is associated with higher adult blood pressure and 
BMI. In contrast, we found less evidence of a difference in 
cardiometabolic health between siblings with differential 
fetal HDP exposure.
Thoulass et al.8 found few studies of adult offspring by exposure 
to maternal HDP and cardiometabolic outcomes. Nevertheless, 
offspring born to women with pregnancies complicated by HDP 
appeared to have slightly higher blood pressure, higher risk of 
hypertension, and higher BMI compared with offspring from 
uncomplicated pregnancies. Our study includes a definition of 
hypertension based on clinical measurement of blood pressure, 
confirming an association between maternal HDP and offspring 
hypertension in middle age that was previously suggested by 
self-report and administrative health care data. In this study, 
we also report a worse OGTT result in participants exposed 
to maternal HDP, which was partly explained by higher BMI. 
Kajantie et al.5 have previously reported offspring exposed to 
maternal hypertension in pregnancy to have increased risk of 
type 2 diabetes, defined as collecting prescriptions on diabetic 
medications in late middle age.
When analyzing siblings discordant in HDP exposure, 
we found no difference in cardiometabolic risk factors. 
Although the statistical power is lower in the restricted 
sample compared with the main analyses, the size of the 
effect estimates was also reduced. Alsnes et  al.4 previously 
reported that young adults born to mothers with a 
history of hypertension in pregnancy had a more adverse 
cardiovascular profile, but, consistent with our findings, 
there was little difference between exposed and non-exposed 
siblings. This suggests that the association between exposure 
to maternal HDP and adverse cardiometabolic health might 
partly be explained by a familial propensity, which might 
have genetic, behavioral, or environmental origins.
The main strength of this study is the combination of 
cardiometabolic outcomes collected in a standardized clinical 
setting, the large population-based sample, and the outcome 
registration in early middle age. During the period relevant 
for this study, Sweden had already implemented universal 
maternity care, so the threshold to access care for symptomatic 
women should have been low. Still, the small proportion of 
offspring exposed to maternal HDP was expected,16 and 
we have, therefore, not analyzed outcomes by type of HDP. 
Table 1. Cardiometabolic risk factors at age 40 years in offspring 
exposed to maternal HDP
 Mean differencea 95% CI P
BMI, kg/m2
 Model I 0.88 0.43, 1.32 <0.001
 Model II 0.84 0.40, 1.28 <0.001
 Model III 0.82 0.38, 1.26 <0.001
SBP, mm Hg
 Model I 4.89 3.46, 6.31 <0.001
 Model II 4.72 3.35, 6.09 <0.001
 Model III 3.86 2.56, 5.15 <0.001
DBP, mm Hg
 Model I 3.04 2.01, 4.07 <0.001
 Model II 2.92 1.92, 3.93 <0.001
 Model III 2.29 1.34, 3.24 <0.001
2-hour OGTT glucose, mmol/l
 Model I 0.13 −0.01, 0.27 0.06
 Model II 0.14 0.01, 0.28 0.04
 Model III 0.10 −0.03, 0.24 0.13
Log total serum cholesterolb
 Model I −0.01 −0.03, −0.01 0.27
 Model II −0.01 −0.03, −0.01 0.20
 Model III −0.02 −0.04, 0.00 0.11
Model I only includes exposure to maternal HDP (yes or no).
Model II additionally includes offspring sex (female or male), 
family history of cardiovascular disease (yes or no), and maternal 
diabetes mellitus during pregnancy (yes or no).
Model III additionally includes body mass index (when it is not 
the outcome), smoking (yes or no), and education (9 years or less, 
10–12 years, 12 years or more).
aAll mean differences compared with offspring not exposed to 
maternal HDP.
bResults interpreted as % (×100) difference in mean.
Abbreviations: BMI, body mass index; CI, confidence interval; 
DBP, diastolic blood pressure; HDP, hypertensive disorders of 
pregnancy; OGTT, oral glucose tolerance test; SBP, systolic blood 
pressure.
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Moreover, at the time of the maternal pregnancies in the 1950s 
to 1970s, the distinction between gestational hypertension and 
pre-eclampsia was not yet as distinct as in the contemporary 
clinical setting. We have focused on the ICD diagnoses that 
we deem most likely to signify severe clinical disease, but the 
study is limited by specific data on maternal pre-pregnancy 
hypertension not being available. As we use a regional register 
to collect data on pregnancy-related diagnoses, our sample is 
limited to those born in the same part of Sweden and who also 
attended the standardized clinical visits. We do not expect this 
to induce any major bias, as we do not think relocating before 
middle age has any strong implications for the association 
between exposure to maternal HDP and cardiometabolic risk 
factors in middle age.
Ascertaining exposure to maternal HDP in adult offspring 
in a clinical setting is not feasible. However, our results suggest 
that the children of women with a history of HDP should 
be considered concomitant targets of prevention. It has 
previously been suggested that family interventions targeting 
cardiometabolic health might be suitable in women with a 
history of HDP.17 As differences were largely attenuated when 
we accounted for familial factors, this study supports targeting 
all siblings and not only those with direct fetal exposure to HDP.
To summarize, we report an association between 
maternal HDP and worse cardiometabolic status at age 
40  years in exposed offspring, including a 67% increased 
risk of hypertension. Further analyses suggested that these 
associations might be explained by shared familial factors. 
Regardless, interventions targeting women with a history 
of HDP to promote cardiometabolic health post-pregnancy 
should also consider their children, perhaps through family-
based approaches.
SUPPLEMENTARY DATA
Supplementary data are available at American Journal of 
Hypertension online.
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